Miron Weinreb
Department of Oral Biology
Maurice and Gabriela Goldschleger School of Dental Medicine
Tel Aviv University
Israel
Name/email consistency: high
- Prostaglandin E2 (PGE2) increases the number of rat bone marrow osteogenic stromal cells (BMSC) via binding the EP4 receptor, activating sphingosine kinase and inhibiting caspase activity. Weinreb, M., Shamir, D., Machwate, M., Rodan, G.A., Harada, S., Keila, S. Prostaglandins Leukot. Essent. Fatty Acids (2006)
- Experimental cholestatic liver disease through bile-duct ligation in rats results in skeletal fragility and impaired osteoblastogenesis. Weinreb, M., Pollak, R.D., Ackerman, Z. J. Hepatol. (2004)
- Inhibition of cyclo-oxigenase-2 activity does not abolish the anabolic effect of prostaglandin E2 in vivo or in vitro. Weinreb, M., Kelner, A., Keila, S. J. Endocrinol. (2002)
- Rat osteoclast precursors in vivo express a vitronectin receptor and a chloride-bicarbonate exchanger. Weinreb, M., Halperin, D. Connect. Tissue Res. (1998)
- Systemic administration of an anabolic dose of prostaglandin E2 induces early-response genes in rat bones. Weinreb, M., Rutledge, S.J., Rodan, G.A. Bone (1997)